HHS stands by anthrax vaccine agreement with Emergent

11/19/2007 | American City Business Journals

The HHS is committed to finishing its $400 million deal with Emergent BioSolutions for supplies of the anthrax vaccine BioThrax, the company announced. Emergent already released $42 million worth of BioThrax doses for pre-exposure vaccination. Approval of the drug as a post-exposure vaccine would entitle the company to another $11.5 million from the HHS.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC